Keywords: pronova, 4th-qtr, ebita, boosted, omacor, lysaker, norway-based
Pronova's 4th-qtr EBITA boosted by Omacor
Article | 18 February 2008
Lysaker, Norway-based Pronova BioPharma says strong demand for Omacor (concentrated omega-3 polyunsaturated fatty acids), up 61% year-on-year, helped fourth-quarter 2007 earnings before ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
